Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) SHH

27.08

-0.51(-1.85%)

Updated at February 13 03:00PM

Currency In CNY

Valuation

Market Cap3.33B
Enterprise Value3.51B
P/E Ratio24.85
PEG Ratio5.17
Price/Sales Ratio2.79
Price/Book Ratio2.08
Enterprise/Revenue2.98
Enterprise/EBITDA20.77

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.11
Operating Margin0.13

Management Effectiveness

Return On Assets0.06
Return On Equity0.09

Income Statement

Revenue1.3B
Revenue/Share9.69
Gross Profit367.27M
EBITDA302.58M
Net Income146.42M
Diluted EPS1.08

Balance Sheet

Total Cash370.35M
Total Cash/Share2.73
Total Debt611.3M
Total Debt/Equity0.35
Current Ratio1.29
Book Value Per Share13.04

Price History

52-Week Change9.64
52-Week High33.34
52-Week Low19.97
Moving Average 50 Days26.92
Moving Average 200 Days28.16

Statistics

Average Volume868,703
Shares Outstanding135.44M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.4
Trailing Annual Dividend Yield1.48
Payout Ratio0.44
Last Split Factor7:5
Last Split DateMay 27, 2020